Guardant Health
GH
#1566
Rank
โ‚ฌ11.35 B
Marketcap
87,45ย โ‚ฌ
Share price
-5.99%
Change (1 day)
154.05%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2025 : -โ‚ฌ0.31 Billion

According to Guardant Health 's latest financial reports the company has -โ‚ฌ0.31 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-โ‚ฌ0.14 Billion-193.49%
2023-12-31$โ‚ฌ0.14 B155.86%
2022-12-31$โ‚ฌ56.1 M-90.15%
2021-12-31$โ‚ฌ0.56 B-48.32%
2020-12-31$โ‚ฌ1.10 B45.59%
2019-12-31$โ‚ฌ0.75 B64.96%
2018-12-31$โ‚ฌ0.45 B78.41%
2017-12-31$โ‚ฌ0.25 B239.46%
2016-12-31$โ‚ฌ75.76 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Natera
NTRA
โ‚ฌ1.07 B-453.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ1.81 B-697.69%๐Ÿ‡บ๐Ÿ‡ธ USA